Brief: Theravance Biopharma Q2 Operating Income USD -2.725 Million
12/08/2025 21:05
Aug 12 (Reuters) - Theravance Biopharma Q2 revenue USD 7.5 million vs. IBES estimate USD 26 million. Q2 net income USD 54.835 million Q2 adjusted net income USD -4.225 million vs. IBES estimate USD -12.3 million Q2 EPS USD 1.08
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy